According to Catalent's latest financial reports the company's total assets are $9.98 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-06-30 | $10.77 B | 2.56% |
2022-06-30 | $10.50 B | 15.32% |
2021-06-30 | $9.11 B | 17.17% |
2020-06-30 | $7.77 B | 25.76% |
2019-06-30 | $6.18 B | 36.48% |
2018-06-30 | $4.53 B | 31.17% |
2017-06-30 | $3.45 B | 11.75% |
2016-06-30 | $3.09 B | -1.5% |
2015-06-30 | $3.13 B | 1.56% |
2014-06-30 | $3.09 B | 4.77% |
2013-06-30 | $2.94 B | -6.04% |
2012-06-30 | $3.13 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Supernus Pharmaceuticals
SUPN | $1.27 B | -87.21% | ๐บ๐ธ USA |
Jazz Pharmaceuticals JAZZ | $11.39 B | 14.07% | ๐ฎ๐ช Ireland |
Aerie Pharmaceuticals AERI | $0.37 B | -96.24% | ๐บ๐ธ USA |
Intercept Pharmaceuticals
ICPT | $0.39 B | -96.06% | ๐บ๐ธ USA |